Hosted on MSN6m
Magnet Biomedicine and Lilly link for molecular glue therapeutics
Magnet Biomedicine has entered a partnership and licence agreement with Eli Lilly to discover, develop and commercialise ...
African drugmaker Aspen says new Latam and Eli Lilly portfolio boosting earnings
By Nqobile Dludla JOHANNESBURG (Reuters) -Aspen Pharmacare posted a 5% rise in half-year earnings on Monday and said it ...
WBAA49m
Indiana joins states calling for the FDA to clamp down on counterfeit weight loss drugs
Over 30 state attorneys general including in Indiana, Kentucky, and Ohio have urged the Federal Food and Drug Administration ...
As baby boomers turn 80, there aren't enough doctors to treat 'emergency levels' of dementia patients
The lifetime risk of dementia after age 55 is about 42%, according to a recent study published in the journal Nature Medicine. Around 1 million adults in the U.S. are projected to develop dementia ...